Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 5Y4TL | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 5Y4TL | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | IM / RA |
rash; pain all over; Hives; swollen joints/ right ankle joint was extremely swollen; This non-serious case was reported by a consumer via call center representative and described the occurrence of rash in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of injection site pain (1st dose received on an unknown date in September 2024 and had mild common systems as far as pain and redness at the injection site, for tolerance of 1st dose refer case US2025022951). On 28-JAN-2025, the patient received the 2nd dose of Shingrix (intramuscular, right arm). On 28-JAN-2025, immediately after receiving Shingrix, the patient experienced rash (Verbatim: rash), general body pain (Verbatim: pain all over), hives (Verbatim: Hives) and swollen joints (Verbatim: swollen joints/ right ankle joint was extremely swollen). The patient was treated with antibiotics. The outcome of the rash, general body pain, hives and swollen joints were not resolved. The reporter considered the rash, general body pain, hives and swollen joints to be unrelated to Shingrix. The company considered the rash, general body pain, hives and swollen joints to be unrelated to Shingrix. Linked case(s) involving the same patient: US2025022951 Additional Information: GSK Receipt Date: 24-FEB-2025 The patient was the reporter. The patient received the 2nd dose of Shingrix on 28th January 2025 and almost immediately started having rash, pain all over and hives. A little longer afterwards reporter reported swollen joints, right ankle joint was extremely swollen. Reporter had been to a few doctors including her dermatologist, Local healthcare professional. Reporter was placed on steroids and was given antibiotic injection today on 24th February 2025. at the healthcare professional office. Reporter asked a couple of her adverse event report be emailed to her.; Sender's Comments: US-GSK-US2025022951:SAME PATIENT